Types of Cancer We Treat

Breast Cancer

We build your team of breast cancer experts based on your needs, providing personalized, compassionate care.

First, we identify the specific type of breast cancer using microscopic analysis, genetic testing, and imaging. Then, we create an individualized treatment plan for you. At the Breast Cancer Center, part of NYU Langone’s Perlmutter Cancer Center, our experts provide the most advanced treatments, such as breast-conserving surgery and targeted drugs, and our researchers evaluate promising new treatments for breast cancer in clinical trials.

We offer comprehensive support services including fertility preservation counseling, psychological support, and integrative therapies.

We counsel women who are at high risk for developing breast cancer, and our experts frequently provide second opinions.

 

Find a Doctor & Schedule
Diagnosis
Surgery
Breast Reconstruction
Chemotherapy & Other Systemic Therapies
Radiation Therapy

Related News

At High Risk for Cancer, This Patient Embraced Prevention
Read Story
‘OK, I Can Do This’—How One Patient Dealt with Breast Cancer
Read Story
Study Suggests Some People Can Skip Radiation After Surgery
Read Story
New Drug May Treat More People With Metastatic Breast Cancer
Read Story
A Commute Is What It Took to Get the ‘Best’ Cancer Treatment
Read Story
New Treatment Targets Gene Changes in Early Breast Cancer
Read Story
Medical Oncologist Advances Breast Cancer Clinical Trials
Read Story
Breast Cancer Survivor Maribel Ramos Tells Her Story
Read Story
Can Artificial Intelligence Perfect Mammography?
Read Story
Cancer Immunotherapies Provide People Better Quality of Life
Read Story
Novel Program Helps Underserved Women Beat Breast Cancer
Read Story
How Teamwork Saved This 44-Year-Old with Breast Cancer
Read Story

Clinical Trials and Research Studies

Phase 5

PHASE 1/2A DOSE ESCALATION FINDING AND EXPANSION STUDY EVALUATING SAFETY TOLERABILITY PHARMACOKINETICS PHARMACODYNAMICS AND ANTI TUMOR ACTIVITY OF PF-07104091 AS A SINGLE AGENT AND IN COMBINATION THERAPY

Learn More

Phase 1

Phase 1 Open-Label Multicenter Dose Escalation Study of mRNA-2752 a Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L IL-23 and IL-36? for Intratumoral Injection Alone and in Combination with Immune Checkpoint Blockade

Learn More

Phase 2

A Phase II Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive HER-2 Negative Advanced/Metastatic Breast Cancer Patients: Big Ten Cancer Research Consortium BTCRC-BRE16-042

Learn More

Phase 3

NRG-BR007: A PHASE III CLINICAL TRIAL EVALUATING DE-ESCALATION OF BREAST RADIATION FOR CONSERVATIVE TREATMENT OF STAGE I HORMONE SENSITIVE HER2-NEGATIVE ONCOTYPE RECURRENCE SCORE = 18 BREAST CANCER

Learn More
View All Related Clinical Trials (21)